These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
393 related items for PubMed ID: 22859238
1. Treatment of nail psoriasis with TNF-α or IL12/23 inhibitors. Jemec GB, Ibler KS. J Drugs Dermatol; 2012 Aug; 11(8):939-42. PubMed ID: 22859238 [Abstract] [Full Text] [Related]
2. Anti-TNF agents and nail psoriasis: a single-center, retrospective, comparative study. Kyriakou A, Patsatsi A, Sotiriadis D. J Dermatolog Treat; 2013 Jun; 24(3):162-8. PubMed ID: 22136334 [Abstract] [Full Text] [Related]
3. TNF-α antagonists and nail psoriasis: an open, 24-week, prospective cohort study in adult patients with psoriasis. Saraceno R, Pietroleonardo L, Mazzotta A, Zangrilli A, Bianchi L, Chimenti S. Expert Opin Biol Ther; 2013 Apr; 13(4):469-73. PubMed ID: 23157654 [Abstract] [Full Text] [Related]
4. Interventions for nail psoriasis. de Vries AC, Bogaards NA, Hooft L, Velema M, Pasch M, Lebwohl M, Spuls PI. Cochrane Database Syst Rev; 2013 Jan 31; (1):CD007633. PubMed ID: 23440816 [Abstract] [Full Text] [Related]
9. Multiple lentigines in areas of resolving psoriatic plaques after ustekinumab therapy. Gutiérrez-González E, Batalla A, de la Mano D. Dermatol Online J; 2014 Apr 16; 20(4):22338. PubMed ID: 24746301 [Abstract] [Full Text] [Related]
10. A 36-week retrospective open trial comparing the efficacy of biological therapies in nail psoriasis. Bardazzi F, Antonucci VA, Tengattini V, Odorici G, Balestri R, Patrizi A. J Dtsch Dermatol Ges; 2013 Nov 16; 11(11):1065-70. PubMed ID: 24119121 [Abstract] [Full Text] [Related]
12. Nail psoriasis: a retrospective study on the effectiveness of systemic treatments (classical and biological therapy). Sánchez-Regaña M, Sola-Ortigosa J, Alsina-Gibert M, Vidal-Fernández M, Umbert-Millet P. J Eur Acad Dermatol Venereol; 2011 May 16; 25(5):579-86. PubMed ID: 21198950 [Abstract] [Full Text] [Related]
13. Efficacy of ustekinumab in nail psoriasis and improvement in nail-associated quality of life in a population treated with ustekinumab for cutaneous psoriasis: an open prospective unblinded study. Rigopoulos D, Gregoriou S, Makris M, Ioannides D. Dermatology; 2011 May 16; 223(4):325-9. PubMed ID: 22134046 [Abstract] [Full Text] [Related]
14. Biological therapy and nail psoriasis. Lawry M. Dermatol Ther; 2007 May 16; 20(1):60-7. PubMed ID: 17403261 [Abstract] [Full Text] [Related]
15. Association between biologic therapies for chronic plaque psoriasis and cardiovascular events: a meta-analysis of randomized controlled trials. Ryan C, Leonardi CL, Krueger JG, Kimball AB, Strober BE, Gordon KB, Langley RG, de Lemos JA, Daoud Y, Blankenship D, Kazi S, Kaplan DH, Friedewald VE, Menter A. JAMA; 2011 Aug 24; 306(8):864-71. PubMed ID: 21862748 [Abstract] [Full Text] [Related]
16. Treatment of nail psoriasis with adalimumab: an open label unblinded study. Rigopoulos D, Gregoriou S, Lazaridou E, Belyayeva E, Apalla Z, Makris M, Katsambas A, Ioannides D. J Eur Acad Dermatol Venereol; 2010 May 24; 24(5):530-4. PubMed ID: 19807825 [Abstract] [Full Text] [Related]
17. Effectiveness of systemic treatment agents on psoriatic nails: a comparative study. Demirsoy EO, Kıran R, Salman S, Cağlayan C, Aktürk AS, Bayramgurler D, Bilen N. J Drugs Dermatol; 2013 Sep 24; 12(9):1039-43. PubMed ID: 24002153 [Abstract] [Full Text] [Related]
18. The status of biologic therapies in the treatment of moderate to severe psoriasis. Menter A. Cutis; 2009 Oct 24; 84(4 Suppl):14-24. PubMed ID: 19916298 [Abstract] [Full Text] [Related]